Global Chronic Myeloid Leukemia (CML) Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 120 pages | ID: GB5CAC739F2BEN
LP Information

Abstracts

According to this study, the global Chronic Myeloid Leukemia (CML) Treatment market size will reach US$ million by 2031.

Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Chronic Myeloid Leukemia (CML) Treatment Industry Forecast” looks at past sales and reviews total world Chronic Myeloid Leukemia (CML) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Myeloid Leukemia (CML) Treatment sales for 2025 through 2031. With Chronic Myeloid Leukemia (CML) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Myeloid Leukemia (CML) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Chronic Myeloid Leukemia (CML) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chronic Myeloid Leukemia (CML) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Myeloid Leukemia (CML) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Myeloid Leukemia (CML) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Myeloid Leukemia (CML) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Myeloid Leukemia (CML) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Targeted Therapy
• Chemotherapy
• Radiation Therapy
• Splenectomy
• Stem Cell Transplant

Segmentation by Application:

• Hospitals
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis AG
• Bristol-Myers Squibb
• Teva Pharmaceuticals Industries Ltd.
• ARIAD Pharmaceuticals, Inc.
• Pfizer, Inc.
• Hospira, Inc.
• Prism Pharmaceuticals
• Incyte Corporation
• Bio-Path Holdings
• Stragen Pharma SA
• Otsuka Pharmaceutical Co., Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size (2020-2031)
  2.1.2 Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Chronic Myeloid Leukemia (CML) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Chronic Myeloid Leukemia (CML) Treatment Segment by Type
  2.2.1 Targeted Therapy
  2.2.2 Chemotherapy
  2.2.3 Radiation Therapy
  2.2.4 Splenectomy
  2.2.5 Stem Cell Transplant
2.3 Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
  2.3.1 Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
2.4 Chronic Myeloid Leukemia (CML) Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinic
  2.4.3 Others
2.5 Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
  2.5.1 Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)

3 CHRONIC MYELOID LEUKEMIA (CML) TREATMENT MARKET SIZE BY PLAYER

3.1 Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Player
  3.1.1 Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Player (2020-2025)
  3.1.2 Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CHRONIC MYELOID LEUKEMIA (CML) TREATMENT BY REGION

4.1 Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2020-2025)
4.2 Global Chronic Myeloid Leukemia (CML) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chronic Myeloid Leukemia (CML) Treatment Market Size Growth (2020-2025)
4.4 APAC Chronic Myeloid Leukemia (CML) Treatment Market Size Growth (2020-2025)
4.5 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2020-2025)
5.2 Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025)
5.3 Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2020-2025)
6.2 APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025)
6.3 APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2020-2025)
7.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025)
7.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment by Region (2020-2025)
8.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CHRONIC MYELOID LEUKEMIA (CML) TREATMENT MARKET FORECAST

10.1 Global Chronic Myeloid Leukemia (CML) Treatment Forecast by Region (2026-2031)
  10.1.1 Global Chronic Myeloid Leukemia (CML) Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.1.3 APAC Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.1.4 Europe Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.1.5 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Forecast
10.2 Americas Chronic Myeloid Leukemia (CML) Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.2.2 Canada Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.2.3 Mexico Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.2.4 Brazil Market Chronic Myeloid Leukemia (CML) Treatment Forecast
10.3 APAC Chronic Myeloid Leukemia (CML) Treatment Forecast by Region (2026-2031)
  10.3.1 China Chronic Myeloid Leukemia (CML) Treatment Market Forecast
  10.3.2 Japan Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.3.3 Korea Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.3.4 Southeast Asia Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.3.5 India Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.3.6 Australia Market Chronic Myeloid Leukemia (CML) Treatment Forecast
10.4 Europe Chronic Myeloid Leukemia (CML) Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.4.2 France Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.4.3 UK Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.4.4 Italy Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.4.5 Russia Market Chronic Myeloid Leukemia (CML) Treatment Forecast
10.5 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.5.2 South Africa Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.5.3 Israel Market Chronic Myeloid Leukemia (CML) Treatment Forecast
  10.5.4 Turkey Market Chronic Myeloid Leukemia (CML) Treatment Forecast
10.6 Global Chronic Myeloid Leukemia (CML) Treatment Forecast by Type (2026-2031)
10.7 Global Chronic Myeloid Leukemia (CML) Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Chronic Myeloid Leukemia (CML) Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis AG
  11.1.1 Novartis AG Company Information
  11.1.2 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis AG Main Business Overview
  11.1.5 Novartis AG Latest Developments
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Information
  11.2.2 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bristol-Myers Squibb Main Business Overview
  11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Teva Pharmaceuticals Industries Ltd.
  11.3.1 Teva Pharmaceuticals Industries Ltd. Company Information
  11.3.2 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Teva Pharmaceuticals Industries Ltd. Main Business Overview
  11.3.5 Teva Pharmaceuticals Industries Ltd. Latest Developments
11.4 ARIAD Pharmaceuticals, Inc.
  11.4.1 ARIAD Pharmaceuticals, Inc. Company Information
  11.4.2 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 ARIAD Pharmaceuticals, Inc. Main Business Overview
  11.4.5 ARIAD Pharmaceuticals, Inc. Latest Developments
11.5 Pfizer, Inc.
  11.5.1 Pfizer, Inc. Company Information
  11.5.2 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer, Inc. Main Business Overview
  11.5.5 Pfizer, Inc. Latest Developments
11.6 Hospira, Inc.
  11.6.1 Hospira, Inc. Company Information
  11.6.2 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Hospira, Inc. Main Business Overview
  11.6.5 Hospira, Inc. Latest Developments
11.7 Prism Pharmaceuticals
  11.7.1 Prism Pharmaceuticals Company Information
  11.7.2 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Prism Pharmaceuticals Main Business Overview
  11.7.5 Prism Pharmaceuticals Latest Developments
11.8 Incyte Corporation
  11.8.1 Incyte Corporation Company Information
  11.8.2 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Incyte Corporation Main Business Overview
  11.8.5 Incyte Corporation Latest Developments
11.9 Bio-Path Holdings
  11.9.1 Bio-Path Holdings Company Information
  11.9.2 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Bio-Path Holdings Main Business Overview
  11.9.5 Bio-Path Holdings Latest Developments
11.10 Stragen Pharma SA
  11.10.1 Stragen Pharma SA Company Information
  11.10.2 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Stragen Pharma SA Main Business Overview
  11.10.5 Stragen Pharma SA Latest Developments
11.11 Otsuka Pharmaceutical Co., Ltd.
  11.11.1 Otsuka Pharmaceutical Co., Ltd. Company Information
  11.11.2 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offered
  11.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
  11.11.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Chronic Myeloid Leukemia (CML) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Radiation Therapy
Table 6. Major Players of Splenectomy
Table 7. Major Players of Stem Cell Transplant
Table 8. Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
Table 11. Chronic Myeloid Leukemia (CML) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)
Table 14. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Player (2020-2025)
Table 16. Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Products Offered
Table 17. Chronic Myeloid Leukemia (CML) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Region (2020-2025)
Table 22. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Country (2020-2025)
Table 26. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
Table 28. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)
Table 30. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Region (2020-2025)
Table 32. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Country (2020-2025)
Table 36. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Chronic Myeloid Leukemia (CML) Treatment
Table 42. Key Market Challenges & Risks of Chronic Myeloid Leukemia (CML) Treatment
Table 43. Key Industry Trends of Chronic Myeloid Leukemia (CML) Treatment
Table 44. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Novartis AG Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 49. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 50. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novartis AG Main Business
Table 52. Novartis AG Latest Developments
Table 53. Bristol-Myers Squibb Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 54. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 55. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Bristol-Myers Squibb Main Business
Table 57. Bristol-Myers Squibb Latest Developments
Table 58. Teva Pharmaceuticals Industries Ltd. Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 59. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 60. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Teva Pharmaceuticals Industries Ltd. Main Business
Table 62. Teva Pharmaceuticals Industries Ltd. Latest Developments
Table 63. ARIAD Pharmaceuticals, Inc. Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 64. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 65. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. ARIAD Pharmaceuticals, Inc. Main Business
Table 67. ARIAD Pharmaceuticals, Inc. Latest Developments
Table 68. Pfizer, Inc. Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 69. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 70. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Pfizer, Inc. Main Business
Table 72. Pfizer, Inc. Latest Developments
Table 73. Hospira, Inc. Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 74. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 75. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Hospira, Inc. Main Business
Table 77. Hospira, Inc. Latest Developments
Table 78. Prism Pharmaceuticals Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 79. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 80. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Prism Pharmaceuticals Main Business
Table 82. Prism Pharmaceuticals Latest Developments
Table 83. Incyte Corporation Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 84. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 85. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Incyte Corporation Main Business
Table 87. Incyte Corporation Latest Developments
Table 88. Bio-Path Holdings Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 89. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 90. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Bio-Path Holdings Main Business
Table 92. Bio-Path Holdings Latest Developments
Table 93. Stragen Pharma SA Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 94. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 95. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Stragen Pharma SA Main Business
Table 97. Stragen Pharma SA Latest Developments
Table 98. Otsuka Pharmaceutical Co., Ltd. Details, Company Type, Chronic Myeloid Leukemia (CML) Treatment Area Served and Its Competitors
Table 99. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offered
Table 100. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 102. Otsuka Pharmaceutical Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Myeloid Leukemia (CML) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Chronic Myeloid Leukemia (CML) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Chronic Myeloid Leukemia (CML) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Chronic Myeloid Leukemia (CML) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type in 2024
Figure 10. Chronic Myeloid Leukemia (CML) Treatment in Hospitals
Figure 11. Global Chronic Myeloid Leukemia (CML) Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Chronic Myeloid Leukemia (CML) Treatment in Clinic
Figure 13. Global Chronic Myeloid Leukemia (CML) Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Chronic Myeloid Leukemia (CML) Treatment in Others
Figure 15. Global Chronic Myeloid Leukemia (CML) Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application in 2024
Figure 17. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Player in 2024
Figure 18. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Chronic Myeloid Leukemia (CML) Treatment Value Market Share by Country in 2024
Figure 24. United States Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Chronic Myeloid Leukemia (CML) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Chronic Myeloid Leukemia (CML) Treatment Market Size 2026-2031 ($ millions)